PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
11333265-5	2001	Expression of Gal3ST-4 in COS-7 cells produced a sulfotransferase activity that catalyzes the transfer of [(35)S]sulfate to the C-3" position of Gal beta 1-->3GalNAc alpha 1-O-Bn.	3galnac	161-168	galactose-3-O-sulfotransferase 4	Homo sapiens	14-22
19470101-3	2009	In this study, we report that the At3g48820 gene (Gene ID: 824043) codes for a Golgi resident protein lacking the ability to transfer SA to asialofetuin or Galbeta1,3GalNAc and Galbeta1,4GlcNAc oligosaccharide acceptors.	3galnac	165-172	Glycosyltransferase family 29 (sialyltransferase) family protein	Arabidopsis thaliana	34-43
12379642-1	2002	The mammalian Galbeta1,3GalNAc-specific alpha2,3-sialyltransferase (ST3Gal I) was expressed as a secreted glycoprotein in High Five (Trichoplusia ni) cells.	3galnac	23-30	ST3 beta-galactoside alpha-2,3-sialyltransferase 1	Homo sapiens	68-76
12145186-6	2002	Homology modeling of the C. elegans 16-kDa galectin CRD revealed that a shorter loop containing residues 66-69, which enables interactions of Glu(67) with both axial and equatorial -OH at C-3 of GlcNAc (in Galbeta1,4GlcNAc) or at C-4 of GalNAc (in Galbeta1,3GalNAc), provides the structural basis for this novel carbohydrate specificity.	3galnac	257-264	Galectin	Caenorhabditis elegans	43-51
11333265-6	2001	Gal3ST-4 recognizes Gal beta 1-->3GalNAc and Gal beta 1-->3(GlcNAc beta 1-->6)GalNAc as good substrates, but not Gal beta 1-->3GalNAc(OH) or Gal beta 1-->3/4GlcNAc.	3galnac	36-43	galactose-3-O-sulfotransferase 4	Homo sapiens	0-8
11333265-6	2001	Gal3ST-4 recognizes Gal beta 1-->3GalNAc and Gal beta 1-->3(GlcNAc beta 1-->6)GalNAc as good substrates, but not Gal beta 1-->3GalNAc(OH) or Gal beta 1-->3/4GlcNAc.	3galnac	138-145	galactose-3-O-sulfotransferase 4	Homo sapiens	0-8
10203360-12	1999	Only the asialo-Galbeta1,3GalNAc chain was identified in the fraction HN IgA1 by gas-phase hydrazinolysis.	3galnac	25-32	immunoglobulin heavy constant alpha 1	Homo sapiens	73-77
11469335-1	2000	A non natural glycosphingolipid containing the mucin derived, cancer associated disaccharide moiety Galbeta1-->3GalNAc, the T-antigen, alpha linked to a ceramide, has been synthesised via the protected disaccharide glycosyl trichloroacetimidate.	3galnac	114-121	LOC100508689	Homo sapiens	47-52
10211703-3	1998	Approximately 91% of the radioactivity released from PSGL-1 was recovered in five O-linked glycans: GalNAc (approximately 4% of the total structures), Galp, 3GalNAc (36%), and Galbeta, 3GalNAc substituted with one (45%), two (6%), or three (3%) N-acetyllactosamine repeat units.	3galnac	185-192	selectin P ligand	Homo sapiens	53-59
9884401-0	1999	UDP-GlcNAc:Galbeta1-->3GalNAc (GlcNAc to GalNAc) beta1-->6N-acetylglucosaminyltransferase holds a key role on the control of CD15s expression in human pre-B lymphoid cell lines.	3galnac	25-32	fucosyltransferase 4	Homo sapiens	131-135
9884401-8	1999	(4) By contrast, the enzyme activities and transcripts of UDP-GlcNAc:Galbeta1-->3GalNAc (GlcNAc to GalNAc) beta1-->6 N -acetylglucosaminyltransferase (Core2GnT) had significant correlation with the cell surface expression of sLexantigen.	3galnac	83-90	glucosaminyl (N-acetyl) transferase 1	Homo sapiens	157-165
9530955-8	1998	The neutral saccharides from both sources contain three common structures, namely Gal1 --> 3GalNAc, GlcNAc1 --> 6 (Gal1 --> 3) GalNAc and Gal1 --> 4GlcNAc --> 6 (Gal1 --> 3)GalNAc.	3galnac	94-101	galectin 1	Homo sapiens	82-86
10211703-3	1998	Approximately 91% of the radioactivity released from PSGL-1 was recovered in five O-linked glycans: GalNAc (approximately 4% of the total structures), Galp, 3GalNAc (36%), and Galbeta, 3GalNAc substituted with one (45%), two (6%), or three (3%) N-acetyllactosamine repeat units.	3galnac	157-164	selectin P ligand	Homo sapiens	53-59
9653936-3	1998	In this experiment, the number of non-substituted N-acetylgalactosamines and Galbeta1,3GalNAc residues, as the core O-linked oligosaccharide structure per heavy chain of normal human serum IgA1, was estimated by digestion of the asialo-hinge glycopeptide with alpha-N-acetylgalactosaminidase (GalNAc-ase) or endo-alpha-N-acetylgalactosaminidase (endo-GalNAc-ase).	3galnac	86-93	immunoglobulin heavy constant alpha 1	Homo sapiens	189-193
7538131-6	1995	The majority of the O-glycans in GlyCAM-1 contain the T-antigen, i.e. Gal beta 1-->3GalNAc, which is incorporated into the core-2 structure, i.e. Gal beta 1-->3[GlcNAc beta 1-->6]GalNAc or larger core structures with additional GlcNAc residues.	3galnac	86-93	glycosylation dependent cell adhesion molecule 1 (pseudogene)	Homo sapiens	33-41
2449438-13	1988	Elimination of sialic acid slightly increased the activity, and subsequent elimination of galactose did not alter the activity; however, removal of the Gal beta 1----3GalNAc residue by endo-alpha-N-acetylgalactosaminidase from desialylated glycopeptide A resulted in total inactivation of the reactivity with FDC-6 antibody.	3galnac	166-173	alpha-N-acetylgalactosaminidase	Homo sapiens	190-221